Literature DB >> 31495546

Prediction of prostate cancer aggressiveness with a combination of radiomics and machine learning-based analysis of dynamic contrast-enhanced MRI.

B Liu1, J Cheng2, D J Guo1, X J He1, Y D Luo1, Y Zeng3, C M Li4.   

Abstract

AIM: To investigate whether the combination of radiomics and automatic machine learning-based classification of original images from multiphase dynamic contrast-enhanced (DCE)-magnetic resonance imaging (MRI) can predict prostate cancer (PCa) aggressiveness before biopsy.
MATERIALS AND METHODS: Forty consecutive biopsy-confirmed PCa patients were included. Biopsy was performed within 4 weeks after the DCE-MRI examinations. According to the time-signal-intensity curve, lesion segmentation was performed on the first and on the strongest phase of the enhancement on the original DCE-MRI images, and 1,029 quantitative radiomics features were calculated automatically from each lesion, wherein there were three datasets available (Dataset-F, Dataset-S and Dataset-FS). The variance threshold method, select k-best method and least absolute shrinkage and selection operator (LASSO) algorithm were used to reduce the feature dimensions. Five machine learning approaches leveraging cross-validation were employed, and the clinical value of each model was evaluated by area under the receiver operating characteristic curve (AUC). Correlation analysis was performed between the features of the machine learning model that achieved the best classification performance and the Gleason score (GS) of the PCa lesion.
RESULTS: Eight, four, and 16 features were selected as optimal subsets in Dataset-F, -S and -FS, respectively. Among all three datasets, logistic regression (LR)-based analysis with Dataset-FS had the highest predication efficacy (AUC=0.93). Ten features in Dataset-FS showed significantly positively correlation with GS. The model performance of Dataset-F was generally better than that in Dataset-S.
CONCLUSIONS: A combination of radiomics and machine learning-analysis based analysis of the union of the first and strongest phases of original DCE-MRI images can predict PCa aggressiveness non-invasively, accurately, and automatically.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31495546     DOI: 10.1016/j.crad.2019.07.011

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  11 in total

Review 1.  Challenges and opportunities for artificial intelligence in oncological imaging.

Authors:  H M C Cheung; D Rubin
Journal:  Clin Radiol       Date:  2021-04-24       Impact factor: 3.389

2.  Predicting bleeding risk in a Chinese immune thrombocytopenia (ITP) population: development and assessment of a new predictive nomogram.

Authors:  Mingjing Wang; Weiyi Liu; Yonggang Xu; Hongzhi Wang; Xiaoqing Guo; Xiaoqing Ding; Richeng Quan; Haiyan Chen; Shirong Zhu; Teng Fan; Yujin Li; Xuebin Zhang; Yan Sun; Xiaomei Hu
Journal:  Sci Rep       Date:  2020-09-18       Impact factor: 4.379

3.  Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions.

Authors:  Valentina Brancato; Marco Aiello; Luca Basso; Serena Monti; Luigi Palumbo; Giuseppe Di Costanzo; Marco Salvatore; Alfonso Ragozzino; Carlo Cavaliere
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

4.  Associations between Statin/Omega3 Usage and MRI-Based Radiomics Signatures in Prostate Cancer.

Authors:  Yu Shi; Ethan Wahle; Qian Du; Luke Krajewski; Xiaoying Liang; Sumin Zhou; Chi Zhang; Michael Baine; Dandan Zheng
Journal:  Diagnostics (Basel)       Date:  2021-01-07

5.  Predictive value of neutrophil-to-lymphocyte ratio in diagnosis of early prostate cancer among men who underwent robotic transperineal prostate biopsy.

Authors:  Jingzeng Du; Ee Jean Lim; Hong Hong Huang; Weber Kam On Lau
Journal:  Medicine (Baltimore)       Date:  2021-12-17       Impact factor: 1.817

Review 6.  Medical imaging and nuclear medicine: a Lancet Oncology Commission.

Authors:  Hedvig Hricak; May Abdel-Wahab; Rifat Atun; Miriam Mikhail Lette; Diana Paez; James A Brink; Lluís Donoso-Bach; Guy Frija; Monika Hierath; Ola Holmberg; Pek-Lan Khong; Jason S Lewis; Geraldine McGinty; Wim J G Oyen; Lawrence N Shulman; Zachary J Ward; Andrew M Scott
Journal:  Lancet Oncol       Date:  2021-03-04       Impact factor: 41.316

Review 7.  Artificial Intelligence Based Algorithms for Prostate Cancer Classification and Detection on Magnetic Resonance Imaging: A Narrative Review.

Authors:  Jasper J Twilt; Kicky G van Leeuwen; Henkjan J Huisman; Jurgen J Fütterer; Maarten de Rooij
Journal:  Diagnostics (Basel)       Date:  2021-05-26

8.  Prediction of Pathological Upgrading at Radical Prostatectomy in Prostate Cancer Eligible for Active Surveillance: A Texture Features and Machine Learning-Based Analysis of Apparent Diffusion Coefficient Maps.

Authors:  Jinke Xie; Basen Li; Xiangde Min; Peipei Zhang; Chanyuan Fan; Qiubai Li; Liang Wang
Journal:  Front Oncol       Date:  2021-02-04       Impact factor: 6.244

9.  Prediction of Clinically Significant Cancer Using Radiomics Features of Pre-Biopsy of Multiparametric MRI in Men Suspected of Prostate Cancer.

Authors:  Chidozie N Ogbonnaya; Xinyu Zhang; Basim S O Alsaedi; Norman Pratt; Yilong Zhang; Lisa Johnston; Ghulam Nabi
Journal:  Cancers (Basel)       Date:  2021-12-09       Impact factor: 6.639

10.  Preoperative histogram parameters of dynamic contrast-enhanced MRI as a potential imaging biomarker for assessing the expression of Ki-67 in prostate cancer.

Authors:  Yongsheng Zhang; Zhiping Li; Chen Gao; Jianliang Shen; Mingtao Chen; Yufeng Liu; Zhijian Cao; Peipei Pang; Feng Cui; Maosheng Xu
Journal:  Cancer Med       Date:  2021-06-12       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.